Metastasis to buccinator lymph nodes from upper gingival cancer is rare, and indicates a poor prognosis. We suggest that the ...

Libtayo gained FDA approval as the first immunotherapy for high-risk cutaneous squamous cell carcinoma, promising improved outcomes post-surgery and radiation.

On October 8, 2025, the US FDA approved the immunotherapy cemiplimab-rwlc (Libtayo) for adjuvant treatment of adult patients ...

The decision follows phase 3 trial data showing the immunotherapy cut disease recurrence or death risk by 68% in patients ...

In the U.S., the generic name for Libtayo in its approved indications is cemiplimab-rwlc, with rwlc as the suffix designated in accordance with Nonproprietary Naming of Biological Products Guidance ...

The FDA approved cosibelimab (Unloxcyt) for treating metastatic or locally advanced cutaneous squamous cell carcinoma (CSCC) in adults who are not candidates for curative surgery or radiation.

Skin malignancies are the most common cancers in the United States. 1 Typically, skin cancer is categorized as either melanoma or non­melanoma skin cancer, which is also known as keratinocyte ...

The first reported cases of PKMB appeared in the French literature in the 1960s (Lortat-Jacob & Civatte, 1961). They described a lesion of the glans penis characterized by thick, hyperkeratotic ...

Q. I am in my 60s and live in Australia. For the past 20 years, I’ve had numerous basal and squamous cell skin cancers removed. Every six months, I’d have to get another check and get something ...

WASHINGTON -- President Joe Biden's doctor said Friday that a lesion removed from the president's chest last month was basal cell carcinoma, a common type of skin cancer. Dr. Kevin O'Connor wrote in a ...